HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interleukin-8 receptor antagonists in pulmonary diseases.

Abstract
Inflammatory cells are thought to be instrumental in the pathophysiology of pulmonary diseases, and control of their recruitment and activation in the lung would appear to be an attractive strategy for therapeutic intervention. Interleukin-8 and related CXC chemokines are involved in the function of neutrophils and T cells, and have been implicated in several lung diseases. Small-molecule antagonists of the interleukin-8 receptors have been identified, which may help elucidate the role of interleukin-8 and related chemokines in the pathophysiology of lung diseases.
AuthorsD W Hay, H M Sarau
JournalCurrent opinion in pharmacology (Curr Opin Pharmacol) Vol. 1 Issue 3 Pg. 242-7 (Jun 2001) ISSN: 1471-4892 [Print] England
PMID11712746 (Publication Type: Journal Article, Review)
Chemical References
  • Interleukin-8
  • Receptors, Interleukin-8A
Topics
  • Animals
  • Humans
  • Interleukin-8 (metabolism, physiology)
  • Lung Diseases (drug therapy)
  • Receptors, Interleukin-8A (antagonists & inhibitors, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: